Open Access

Articles selected from Faculty of 1000 in November 2003

Arthritis Res Ther20035:E3

DOI: 10.1186/ar1031

Published: 20 November 2003

Articles selected from Faculty of 1000

Authors’ Affiliations

(1)
Centre for Rheumatic Diseases, Queen Elizabeth Building, Royal Infirmary

References

  1. Grakoui A, Shoukry NH, Woollard DJ, Han JH, Hanson HL, Ghrayeb J, Murthy KK, Rice CM, Walker CM: HCV persistence and immune evasion in the absence of memory T cell help. Science. 2003, 302: 659-62. For the Faculty of 1000 evaluation of this article please see: http://arthritis-research.com/viewpoints/ar1031.asp#grakouiView ArticlePubMedGoogle Scholar
  2. Ubersax JA, Woodbury EL, Quang PN, Paraz M, Blethrow JD, Shah K, Shokat KM, Morgan DO: Targets of the cyclin-dependent kinase Cdk1. Nature. 2003, 425: 859-64. For the Faculty of 1000 evaluation of this article please see: http://arthritis-research.com/viewpoints/ar1031.asp#ubersaxView ArticlePubMedGoogle Scholar
  3. Zhong XP, Hainey EA, Olenchock BA, Jordan MS, Maltzman JS, Nichols KE, Shen H, Koretzky GA: Enhanced T cell responses due to diacylglycerol kinase zeta deficiency. Nat Immunol. 2003, 4: 882-90. For the Faculty of 1000 evaluation of this article please see: http://arthritis-research.com/viewpoints/ar1031.asp#zhongView ArticlePubMedGoogle Scholar
  4. Wald D, Qin J, Zhao Z, Qian Y, Naramura M, Tian L, Towne J, Sims JE, Stark GR, Li X: SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat Immunol. 2003, 4: 920-7. For the Faculty of 1000 evaluation of this article please see: http://arthritis-research.com/viewpoints/ar1031.asp#waldView ArticlePubMedGoogle Scholar

Copyright

© BioMed Central Ltd 2003

Advertisement